CClinicalTrials.gg
CompletedNCT07552753Updated Apr 27, 2026

Semi-occlusive Dressing for Pediatric Fingertip Amputations

An observational study in Fingertip Amputation and Finger Injuries, sponsored by Medical University of Graz. Completed at 1 site in Austria. Open to participants aged 0 Years to 17 Years. Per ClinicalTrials.gov, last updated 2026-04-27.

Sponsored by Medical University of Graz · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
24
Ages
0 Years to 17 Years
Sex
All
01

Study summary

The aim of this prospective cohort study is to assess the outcome and pain progression of fingertip (partial) amputations treated with a semi-occlusive wound dressing (regular care) in childhood and adolescence.The main questions it aims to answer are:

  • What is the pain progression of children and adolescents with fingertip amputations treated with semi-occlusive wound dressing?
  • What is the outcome of children and adolescents with fingertip amputations treated with semi-occlusive wound dressing?
Read the detailed description

The semi-occlusive wound dressing has now become an established method for treating fingertip (partial) amputations. Very good outcomes have been published for adults. A retrospective study also reports very good results in children (Schultz et al., 2018). However, prospective studies describing the outcomes and pain progression of semi-occlusive wound dressings for fingertip (partial) amputations in children and adolescents are not available.

All children and adolescents treated at our clinic for fingertip (partial) amputations using semi-occlusive wound therapy will be included in the study-following written informed consent from the patients and/or their parents.

A case report form will be completed for each patient. On the day of the accident, data regarding the injury will be recorded and photographic documentation will be performed. Patients or their parents will be given a pain diary to be completed once daily at home. The first follow-up examination will take place after two days, with additional visits scheduled weekly up to and including five weeks after the injury (these visits are part of routine care and would occur regardless of the study).

As part of the study-specific follow-ups at six months, range of motion of the affected distal phalanx (compared side-to-side) will be assessed, and any nail growth disturbances will be documented. Photographs of the affected fingertip and the contralateral side will be taken. Patient satisfaction will be recorded on a scale from 0 (dissatisfied) to 100 (very satisfied).

The routine treatment of these injuries at our clinic will not be altered by the study. The only study-related interventions are the daily completion of a pain diary and clinical follow-up examinations at six months.

02

Conditions studied

  • Fingertip Amputation
  • Finger Injuries

Browse trials for

Keywords

  • fingertip amputation
  • children
  • semi-occlusive dressing
  • outcome
03

In context

Finger Injuries

23 studies on the registry are indexed under Finger Injuries; 3 are open to participants now.

Browse Finger Injuries studies →

Lead sponsor

Medical University of Graz is the lead sponsor of 459 studies on the registry; 98 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
0 Years to 17 Years
Sexes eligible
All
Sampling method
Non-probability sample

Study population

All children and adolescents treated at our clinic for fingertip (partial) amputations using semi-occlusive wound therapy will be included in the study, following written informed consent from the patients and/or their parents.

Inclusion criteria

  • age 0-17 years
  • fingertip amputations Allen I-IV
  • signed informed consent

Exclusion criteria

Exclusion Criteria:

  • no signed informed consent
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
24 participants (actual)
Patient registry
No

Groups and cohorts

  • fingertip amputation

    children and adolescents with (partial) fingertip amputations (Allen I-IV) treated with semi-occlusive dressings

    Procedure: semi-occlusive dressings

Interventions

  • Proceduresemi-occlusive dressings

    routine care treatment with semi-occlusive dressings

06

What researchers measure

Primary outcomes

  1. Pain Progression

    A pain diary using a visual analogue scale (VAS 0-10); whereas 0 corresponds to no pain and 10 to worst pain

    Time frame: Assessment once daily until end of treatment with semi-occlusive dressings

Secondary outcomes

  1. Length Loss of the finger

    Assessment of the length loss of the finger compared to the uninjured side, measured from the distal palmar grease of the DIP joint to the tip of the finger, measured in mm

    Time frame: once at follow-up at 6 months post-injury

  2. active range of motion

    active range of motion (ROM) of the distal interphalangeal (DIP) joint compared with the corresponding contralateral uninjured finger,measured in ° using a goniometer

    Time frame: once at follow-up at 6 months post-injury

  3. Percentage of patients with nail growth abnormalities

    presence of nail growth abnormalities as assessed by the physician at follow-up

    Time frame: once at follow-up at 6 months post-injury

  4. Satisfaction with the cosmetic results

    At final follow-up the patient and/or parent satisfaction (depending on age) are askd to judge their satisfaction with the treatment outcome usng a visual analogue scale (VAS) ranging from 0-100, whereas 0 ist the least satisfaction and 100 corresponds to the best satisfaction.

    Time frame: once at follow-up at 6 months post-injury

07

Study locations

1 site
  • Department of Pediatric Surgery, Medical University of Graz
    Graz, 8036, Austria
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 27, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07552753
Lead sponsor
Medical University of Graz
Responsible party
Sponsor
First posted
Apr 27, 2026
Start date
Oct 1, 2022
Primary completion
Oct 31, 2024
Completion
Apr 30, 2025
Last update
Apr 27, 2026

Study contacts

Georg Singer, MD
principal investigator · Medical University of Graz

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion